ERBA Diagnostics Inc news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

ERB 2.92 -0.01 (-0.34%)
price chart
ERBA Diagnostics, Inc. Appoints William Creech as Vice President Sales and ...
MIAMI LAKES, Fla., June 20, 2014 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, has appointed William Creech as Vice President Sales and Marketing.
Related articles »  
ERBA Diagnostics, Inc. to Exhibit at AACC 2014 in Chicago, USA
MIAMI LAKES, Fla., July 28, 2014 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, is pleased to announce that it will be exhibiting its full range of products at the world's largest show for ...
Related articles »  
ERBA Diagnostics Schedules Conference Call to Discuss 2014 Second Quarter ...
MIAMI LAKES, Fla., Aug. 7, 2014 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, announced today it will host an earnings call to discuss the Company's second quarter 2014 financial results at ...
Related articles »  
ERBA Diagnostics, Inc. (ERB) in Focus: Stock Rises 6%
ERBA Diagnostics, Inc. (ERB) was a big mover last session, as the company saw its shares rise 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.
ERBA Diagnostics, Inc. Appoints Mohan Gopalkrishnan as Chief Executive ...
MIAMI LAKES, Fla.--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, has appointed Mohan Gopalkrishnan as Chief Executive Officer and Prakash Patel as Controller of ERBA Diagnostics, both ...
ERBA Diagnostics CEO to resign, Gopalkrishnan appointed  South Florida Business Journal (blog)
Related articles »  
ERBA Diagnostics, Inc. Reports First Quarter 2014 Financial Results
MIAMI LAKES, Fla.--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, reported its financial results for the three months ended March 31, 2014.
Related articles »  
ERBA Diagnostics, Inc. Reports Third Quarter 2012 Financial Results
MIAMI--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, reported its financial results for the quarter and nine months ended September 30, 2012.
ERBA Diagnostics Reports 3rd Quarter Financial Results
10, 2014 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, today announced third quarter 2014 financial results.
Erba Diagnostics posts 3Q profit  CNBC
Related articles »  
ERBA Diagnostics, Inc. Receives 510(K) Clearance for the XL200 Clinical ...
MIAMI LAKES, Fla.--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, today announced that it has received clearance from the U.S.
Related articles »  
ERBA Diagnostics Reports 2nd Quarter Financial Results; Consolidation ...
MIAMI LAKES, Fla., Aug. 12, 2014 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, today announced its results of operations for the second quarter of 2014.
Related articles »